Cargando…

RF18 | PSAT149 Joint Function and Quality of Life in Fibrodysplasia Ossificans Progressiva: Results from an International Burden of Illness Survey of Patients and Family Members

INTRODUCTION: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder of progressive heterotopic ossification, resulting in cumulative loss of joint function and severe disability. We present results from an international, cross-sectional FOP Burden of Illness Survey (NCT046653...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böing, Elaine A, Mukaddam, Mona A, Toder, Katherine S, Davis, Michelle, Croskery, Kim, Grandoulier, Anne-Sophie, Kaplan, Frederick S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Bone & Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624537/ http://dx.doi.org/10.1210/jendso/bvac150.467

Ejemplares similares

PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series
por: Almonaei, Khulod, et al.
Publicado: (2022)

SUN-344 Patients with Fibrodysplasia Ossificans Progressiva Have an Increased Prevalence of Cardiac Conduction Abnormalities
por: Kou, Samuel, et al.
Publicado: (2020)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

THU467 Pharmacokinetics And Pharmacodynamics Of Garetosmab In Patients With Fibrodysplasia Ossificans Progressiva
por: Wang, Yuhuan, et al.
Publicado: (2023)

OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
por: Dahir, Kathryn M, et al.
Publicado: (2023)

MON-348 Surgical Management of Bilateral Hip Fracture in a Patient with Fibrodysplasia Ossificans Progressiva Treated with Palovarotene
por: Singh, Sukhmani, et al.
Publicado: (2020)

ODP108 Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Phase III Open-Label PIVOINE Rollover Trial
por: Artyomenko, Alex, et al.
Publicado: (2022)

THU402 New Heterotopic Ossification Lesions In Patients With Fibrodysplasia Ossificans Progressiva Measured By PET/CT vs CT Only
por: Trotter, Dinko Gonzalez, et al.
Publicado: (2023)

ODP103 IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Randomized, Double-Blind, Placebo-Controlled Phase II FALKON Trial
por: Karimian, Negar, et al.
Publicado: (2022)

Compartment Syndrome of the Thigh in a Patient with Fibrodysplasia Ossificans Progressiva
por: Kaplan, Frederick S., et al.
Publicado: (2020)

Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023)

RF18 | PSAT146 Bone Quality in Lean Adults with Metabolic Syndrome
por: Ferri-Guerra, Juliana, et al.
Publicado: (2022)

RF18 | PSAT143 Brain Determinants of Dynamic Bone Remodeling in Females
por: Babey, Muriel, et al.
Publicado: (2022)

RF30 | PSAT178 Severe Hyperparathyroidism in a Newborn: Response to Cinacalcet
por: Welch, Lurah, et al.
Publicado: (2022)

RF30 | PSAT138 Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient with Hypophosphatasia
por: Khanjee, Naveed, et al.
Publicado: (2022)

RF06 | PSAT154 Osteoporosis Likely Increases the Risk of Dementia in Vietnamese Immigrants
por: Kim, Yu N, et al.
Publicado: (2022)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)

RF06 | PSAT171 Impact of GH Administration on Skeletal Endpoints in Adults with Overweight/Obesity
por: Dichtel, Laura, et al.
Publicado: (2022)

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

RF30 | PSAT137 Low Level of Alkaline Phosphatase as a Clue to Noncompliance in Patient with Hypophosphatasia
por: Markovic, Nikolina, et al.
Publicado: (2022)

RF30 | PSAT134 Autosomal Dominant Hereditary Multiple Osteochondromas Misdiagnosed As Paget's Disease of Bone
por: Myers, Kyle, et al.
Publicado: (2022)

RF18 | PSAT166 Hypercalcemia and hypocalcemia during pregnancy are associated with worse maternal and fetal outcomes
por: Arshad, Muhammad Fahad, et al.
Publicado: (2022)

Recent Topics in Fibrodysplasia Ossificans Progressiva
por: Katagiri, Takenobu, et al.
Publicado: (2018)

RF06 | PSAT153 Osteoporosis Screening of Liver Transplant Patients in a Tertiary Urban Medical Center
por: Chancay, Azucena Herrera, et al.
Publicado: (2022)

RF06 | PSAT152 Associations between Bone Mass, Hormone Levels and Body Composition in Postmenopausal Women
por: Fighera, Tayane, et al.
Publicado: (2022)

RF18 | PSAT165 Effect of Age, Gender, & Ethnicity on the Prevalence of Vertebral fractures in Patients with Primary Hyperparathyroidism
por: Al-Bacha, Souad, et al.
Publicado: (2022)

The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
por: Towler, O. Will, et al.
Publicado: (2020)

RF30 | PSAT177 A Case of Hypercalcemia Related to Immune Checkpoint Inhibitor-Induced Sarcoidosis-like Granuloma
por: Donangelo, Ines, et al.
Publicado: (2022)

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis
por: Kaplan, Frederick S., et al.
Publicado: (2012)

RF18 | PSAT162 Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes
por: Haines, Melanie, et al.
Publicado: (2022)

RF30 | PSAT148 Bone Mass and Body Composition Analysis in Transgender Men: A 1 Year Follow Up
por: Orozco, Bruno, et al.
Publicado: (2022)

RF06 | PSAT147 Impairments in volumetric bone mineral density, bone microarchitecture, and estimated strength in women with atypical anorexia nervosa
por: Eddy, Kamryn, et al.
Publicado: (2022)

RF30 | PSAT172 Effects of 12 Months of Alendronate Therapy Subsequent to 12 Months of Denosumab Administration in Women With Anorexia Nervosa
por: Haines, Melanie, et al.
Publicado: (2022)

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva
por: Pignolo, Robert J., et al.
Publicado: (2023)

Quality of life of patients with fibrodysplasia ossificans progressiva
por: Ortiz-Agapito, Fernando, et al.
Publicado: (2015)

Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva
por: Colmenares-Bonilla, Douglas, et al.
Publicado: (2018)

Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
por: Khan, Fatima, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis
por: De Brasi, Daniele, et al.
Publicado: (2021)

RF06 | PSAT155 Are We Following the Recommendations to Screen for and Treat the "Silent Killer" in Our Geriatric Population? A Quality Improvement Project
por: Maradni, Ahmad A, et al.
Publicado: (2022)

Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes
por: Pignolo, Robert J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6p70vvj5ph4tkn7t4ch4f6v942